Eurofins Scientific SE (0MV5.IL)
| Previous close | 47.30 |
| Open | 47.18 |
| Bid | 45.20 x 0 |
| Ask | 47.40 x 0 |
| Day's range | 46.04 - 47.25 |
| 52-week range | 39.60 - 63.74 |
| Volume | |
| Avg. volume | 120,220 |
| Market cap | 10.319B |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | 20.31 |
| EPS (TTM) | 2.28 |
| Earnings date | 24 Jul 2024 |
| Forward dividend & yield | 1.00 (2.03%) |
| Ex-dividend date | 04 Jul 2023 |
| 1y target est | 112.38 |
BloombergEurofins Rejects Muddy Waters Attack as Shares Edge Back Up
(Bloomberg) -- Eurofins Scientific SE rejected allegations made by Carson Block’s Muddy Waters Research that caused its stock to plunge the most in two decades, saying it’s confident in the integrity of its accounts.Most Read from BloombergNvidia Rout Takes Breather as Traders Scour Charts for SupportBuzzFeed Struggles to Sell Owner of Hit YouTube Show ‘Hot Ones’Jain Global Raises $5.3 Billion, Secures Cash From Abu DhabiWikileaks’ Assange Headed to Saipan to Plead Guilty in US CaseIsrael Court
- Investing.com
Eurofins Scientific shares rise as laboratory group denies Muddy Waters claims
Investing.com -- Shares in Eurofins Scientific (EPA:EUFI) rose on Tuesday, paring back some losses posted in the prior session, after the French laboratory group rejected short seller Muddy Waters' (NYSE:WAT) accusations that it had misrepresented its financial statements.
ReutersEurofins denies short seller Muddy Waters' allegations after share fall
Muddy Waters said on Monday it had taken a short position in Eurofins shares and published a report saying Eurofins' financial statements could contain material overstatements of profits, cash balances and other asset values. "It is Eurofins' view that the entirety of allegations and insinuations contained therein is either inaccurate, irrelevant, biased and/or misleading," the firm said in a statement. Eurofins "is completely confident in the integrity of its accounts, operational performance, internal controls and risk management", it said.
